Burn Clinical Trial
Official title:
Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns (Children & Adults)- Protocol MW2008-09-03
Burns represent one of the most severe and dreaded traumas. Burned and traumatized tissue is known as eschar. The dead eschar, if not removed, often becomes heavily contaminated and is the source of local and/or systemic infection or sepsis. The local inflammation and infection destroy healthy surrounding tissues and extends the original damage. In order to prevent these complications, and in order to minimize the risk of infection, it is imperative to evaluate the burn and remove all of the offending eschar at the earliest possible opportunity. This removal of dead tissue is termed "debridement". The most direct debridement method for eschar removal is surgery. Traditional, conservative non-surgical debridement is a lengthy process which often involves many complications. The objectives of this study are as follows: 1. To evaluate the safety and efficacy (exploratory) of DGD in hospitalized patients with Partial Thickness (mid and deep dermal) thermal burns of 4-30% total body surface area (TBSA), but with total burn wounds of no more than 30% TBSA. Measures have already been taken in previous studies involving deeper wounds to control safety parameters (such as pain, fever and infection). Nevertheless, as part of the effort to expand the burn population in the future phase 3 study to the more superficial wound group, it is important to first explore these parameters in a small group involving this burn population. 2. To explore DGD absorption as measured by Pharmacokinetic testing.
on-going recruitment, children and adults ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01302457 -
Oral Care Study on Burn Patients
|
N/A | |
| Completed |
NCT02729259 -
H2O VR for Burns 2015
|
N/A | |
| Completed |
NCT01965340 -
Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission
|
N/A | |
| Withdrawn |
NCT01225107 -
Effect of Cranberry Extract on Infections in Burn Patients
|
N/A | |
| Completed |
NCT01983280 -
The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients
|
N/A | |
| Completed |
NCT00591448 -
Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients
|
N/A | |
| Active, not recruiting |
NCT02083900 -
Use of Banana Leaf Dressing on Donor Site Wounds
|
Phase 2 | |
| Completed |
NCT00242970 -
Hypertrophic Scarring After Facial Burn
|
Phase 2 | |
| Completed |
NCT00585325 -
Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes
|
N/A | |
| Terminated |
NCT00591162 -
Bone Disease in Severely Burned Children
|
Phase 2/Phase 3 | |
| Terminated |
NCT02452255 -
Fenofibrate and Propranolol in Burn Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT03183622 -
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial
|
N/A | |
| Completed |
NCT02427659 -
VR High Tech Pain Control Burn Wound Care
|
N/A | |
| Not yet recruiting |
NCT00253279 -
Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans
|
Phase 1 | |
| Completed |
NCT04516148 -
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
|
Phase 4 | |
| Withdrawn |
NCT02029261 -
Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury
|
||
| Completed |
NCT00993889 -
Virtual Reality Analgesia During Pediatric Physical Therapy
|
N/A | |
| Terminated |
NCT01062191 -
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
|
N/A | |
| Completed |
NCT02394873 -
A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound
|
Phase 1 | |
| Completed |
NCT00239668 -
Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors
|